Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for preparing lovastatin

A technology of lovastatin and seeds, applied in the field of preparation of lovastatin, capable of solving the problems of high production cost and low yield

Active Publication Date: 2014-08-20
TOPFOND PHARMA CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are generally problems such as low output and high production cost in the current production.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing lovastatin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Example 1 Effect of Adding Phenylalanine on Lovastatin Production

[0019] 1.1 The effect of the addition amount of phenylalanine on the biosynthesis of lovastatin

[0020] Prepare the fermentation medium of lovastatin, add the weight ratio phenylalanine shown in Table 1 respectively to the lovastatin fermentation medium, meanwhile, use the fermentation medium without adding phenylalanine as a control, insert soil After Aspergillus terreus was fermented for 216 hours, samples were taken to determine the content of lovastatin. The results are shown in Table 1.

[0021] Table 1, the impact of adding phenylalanine on the output of lovastatin

[0022] Addition of phenylalanine (%)

[0023] As can be seen from the results in Table 1, adding phenylalanine to the fermentation medium can significantly improve the biosynthesis of lovastatin, and the preferred addition range is 0.01-0.03%.

[0024] 1.2 The effect of the addition time of phenylalanine on the yield of...

Embodiment 2

[0029] Example 2 The effect of adding tyrosine on the biosynthesis of lovastatin

[0030] 2.1 The effect of the addition amount of tyrosine on the biosynthesis of lovastatin

[0031] To prepare the fermentation medium of lovastatin, add 0.005%, 0.01%, 0.03%, and 0.05% tyrosine by weight respectively to the lovastatin fermentation medium; meanwhile, use the fermentation medium without adding tyrosine As a control, Aspergillus terreus was inoculated and fermented at 26±1° C. for 216 hours, then samples were taken to determine the content of lovastatin. The results are shown in Table 3.

[0032] Table 3, the impact of adding tyrosine on the yield of lovastatin

[0033] Tyrosine addition (%)

0

0.005

0.01

0.03

0.05

Relative content

100

108

116

115

109

[0034] It can be seen from the results in Table 3 that adding tyrosine to the fermentation medium can obviously improve the biosynthesis of lova...

Embodiment 3

[0041] Example 3 Effects of Simultaneous Addition of Phenylalanine and Tyrosine on the Biosynthesis of Lovastatin

[0042]3.1 The effect of simultaneous addition of phenylalanine and tyrosine on the biosynthesis of lovastatin

[0043] Prepare the fermentation medium of lovastatin, add the tyrosine and phenylalanine that are 0.005%, 0.01%, 0.03%, 0.05% by weight respectively in the lovastatin fermentation medium at the same time, meanwhile, without adding tyrosine As a control, the fermentation medium of Aspergillus terreus was inserted into Aspergillus terreus and fermented at 26±1° C. for 216 hours, and then samples were taken to determine the content of lovastatin. The results are shown in Table 5.

[0044] Table 5, adding phenylalanine and tyrosine simultaneously to the influence of lovastatin output

[0045]

[0046] It can be seen from the results in Table 5 that adding phenylalanine and tyrosine to the fermentation medium can significantly improve the biosynthesis...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for preparing lovastatin. The method comprises the step of fermenting an aspergillus terreus strain in a fermentation medium to obtain lovastatin and is characterized by adding phenylalanine and / or tyrosine to the fermentation medium in the fermentation process. The preparation method has the beneficial effects of effectively increasing the yield of lovastatin and lowering the production cost.

Description

technical field [0001] The present invention generally relates to a method for preparing lovastatin, in particular to a method for preparing lovastatin by fermentation. Background technique [0002] Lovastatin (lavostatin) is a HMG-CoA (3-hydroxy-3-methyl-glutaryl coenzyme A) reductase inhibitor (HMG-CoA-RI) microbial drug, which can effectively reduce coronary heart disease and myocardial Infarction morbidity and mortality. Lovastatin is mainly produced by submerged fermentation of Aspergillus terreus and monascus rubber. Monascus rubber is widely used in my country. Monascus rubber not only produces lovastatin (also known as monacolin K, monacolin K), but also produces polyketides that are presumed to be intermediate products of lovastatin biosynthesis The substances monacolin J, L, and X are all HMG-CoA-RI substances, which have a strong function of lowering cholesterol and regulating blood lipids. Aspergillus terreus is the original starting bacterium for lovastatin pr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12P17/06C12R1/66
Inventor 刘守强张宏周周淑梅李武德时新生朱义彬王青孔德周任清华
Owner TOPFOND PHARMA CO LTD